BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antiviral activities of carbocyclic oxetanocin analogues. 1990

T Maruyama, and Y Sato, and T Horii, and H Shiota, and K Nitta, and T Shirasaka, and H Mitsuya, and M Honjo
Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Japan.

9-Cyclobutyladenine (4a), cis- and trans-9-[3- (hydroxymethyl)cyclobutyl]adenine (4b) and 9-[3,3-bis(hydroxymethyl)cyclobutyl]adenine(4d) were prepared from the corresponding cyclobutylamine derivatives (1a, 1b and 1d). Guanine congeners (9a, cis- and trans-9b and 9d) and carbocyclic oxetanocin G (1',2'-trans-9f) were also prepared. Carbocyclic oxetanocin A(1',2'-trans-4f), the preparation of which we have already published, and G were found to be active against herpes simplex virus (type 1 and 2) in vitro, while cis-4b and cis-9b showed an in vitro antiretroviral activity against human immunodeficiency virus (type 1).

UI MeSH Term Description Entries
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014709 Vero Cells A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays. Cell, Vero,Cells, Vero,Vero Cell
D018139 Simplexvirus A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN. Herpes Simplex Virus,Herpesvirus 1, Saimiriine,Herpesvirus 1, Saimirine,Herpesvirus 16, Cercopithecine,Marmoset Virus,Cercopithecine Herpesvirus 16,Herpes Labialis Virus,Herpes-T Virus,Herpesvirus 1 (alpha), Saimirine,Herpesvirus Hominis,Herpesvirus Papio 2,Herpesvirus Platyrhinae,Marmoset Herpesvirus,Saimiriine Herpesvirus 1,Herpes Labialis Viruses,Herpes Simplex Viruses,Herpes T Virus,Herpes-T Viruses,Herpesvirus Homini,Herpesvirus, Marmoset,Herpesviruses, Marmoset,Homini, Herpesvirus,Hominis, Herpesvirus,Labialis Virus, Herpes,Labialis Viruses, Herpes,Marmoset Herpesviruses,Marmoset Viruses,Platyrhinae, Herpesvirus,Saimirine Herpesvirus 1,Simplexviruses,Virus, Herpes Labialis,Viruses, Herpes Labialis

Related Publications

T Maruyama, and Y Sato, and T Horii, and H Shiota, and K Nitta, and T Shirasaka, and H Mitsuya, and M Honjo
Synthesis of cyclobutane nucleoside analogues 3: Preparation of carbocyclic derivatives of oxetanocin.
January 2018, Nucleosides, nucleotides & nucleic acids,
T Maruyama, and Y Sato, and T Horii, and H Shiota, and K Nitta, and T Shirasaka, and H Mitsuya, and M Honjo
Carbocyclic analogues of nucleosides from bis-(Hydroxymethyl)-cyclopentane: synthesis, antiviral and cytostatic activities of adenosine, inosine and uridine analogues.
September 2003, Chemical & pharmaceutical bulletin,
T Maruyama, and Y Sato, and T Horii, and H Shiota, and K Nitta, and T Shirasaka, and H Mitsuya, and M Honjo
Unsaturated and carbocyclic nucleoside analogues: synthesis, antitumor, and antiviral activity.
January 1991, Journal of medicinal chemistry,
T Maruyama, and Y Sato, and T Horii, and H Shiota, and K Nitta, and T Shirasaka, and H Mitsuya, and M Honjo
Synthesis and antiviral and antineoplastic activities of some novel carbocyclic guanosine analogues with a cyclobutane ring.
September 1999, Chemical & pharmaceutical bulletin,
T Maruyama, and Y Sato, and T Horii, and H Shiota, and K Nitta, and T Shirasaka, and H Mitsuya, and M Honjo
Carbocyclic analogues of 5-substituted uracil nucleosides: synthesis and antiviral activity.
February 1983, Journal of medicinal chemistry,
T Maruyama, and Y Sato, and T Horii, and H Shiota, and K Nitta, and T Shirasaka, and H Mitsuya, and M Honjo
Synthesis and antitumor activity of phenyl carbocyclic oxetanocin and related compounds.
July 1996, Chemical & pharmaceutical bulletin,
T Maruyama, and Y Sato, and T Horii, and H Shiota, and K Nitta, and T Shirasaka, and H Mitsuya, and M Honjo
Synthesis and antiviral and cytostatic activities of carbocyclic nucleosides incorporating a modified cyclobutane ring. Part 1: Guanosine analogues.
October 1999, Archiv der Pharmazie,
T Maruyama, and Y Sato, and T Horii, and H Shiota, and K Nitta, and T Shirasaka, and H Mitsuya, and M Honjo
Synthesis, antiviral and cytostatic activities, of carbocyclic nucleosides incorporating a modified cyclopentane ring. IV. Adenosine and uridine analogues.
January 2002, Nucleosides, nucleotides & nucleic acids,
T Maruyama, and Y Sato, and T Horii, and H Shiota, and K Nitta, and T Shirasaka, and H Mitsuya, and M Honjo
Isosteric ribavirin analogues: Synthesis and antiviral activities.
January 2018, Bioorganic & medicinal chemistry letters,
T Maruyama, and Y Sato, and T Horii, and H Shiota, and K Nitta, and T Shirasaka, and H Mitsuya, and M Honjo
Highly stereoselective synthesis of carbocyclic oxetanocin and its related compounds from bicycloamides.
January 1990, Nucleic acids symposium series,
Copied contents to your clipboard!